Home > Literature List > Ginsenoside Rg3 suppresses mast cell-mediated allergic inflammation via MAPK signaling pathway

Ginsenoside Rg3 suppresses mast cell-mediated allergic inflammation via MAPK signaling pathway

Journal name：JGR
Literature No.：
Literature Url：
Date publication：19 February 2018

Please cite this article as: Kee J-Y, Hong S-H, Ginsenoside Rg3 suppresses mast cell-mediated allergic inflammation via MAPK signaling pathway, Journal of Ginseng Research (2018), doi: 10.1016/ j.jgr.2018.02.008.
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

5 purchased from Santa Cruz Biotechnology (Dallas, TX, USA). Ginsenoside Rg3 (CAS no. 14197-60-5, 86 purify: 95–99%) was purchased from Chengdu Biopurify Phytochemical Ltd. (Chengdu, 87 Sichuan, China).